{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:46Z","timestamp":1792783366281,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Science and Technology, Government of India, New Delhi under the Inspire Faculty Award Scheme of AORC","award":["IFA15\/LSBM-154"],"award-info":[{"award-number":["IFA15\/LSBM-154"]}],"id":[{"id":"https:\/\/ror.org\/036h6g940","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Supported by the Department of Bio-Technology, Government of India, New Delhi","award":["BT\/PR9199\/Med\/30\/12\/2007"],"award-info":[{"award-number":["BT\/PR9199\/Med\/30\/12\/2007"]}],"id":[{"id":"https:\/\/ror.org\/036h6g940","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03408-1","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:06:18Z","timestamp":1790309178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective regulation of \u03b22AR-mediated effects on cellular signaling mechanisms is governed by the estrogen receptor status of the breast cancer cell lines"],"prefix":"10.1007","volume":"43","author":[{"given":"Hannah P.","family":"Priyanka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday P.","family":"Pratap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul S.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasankaran Munusamy","family":"Ponnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Vasantharekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Elizabeth","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"ThyagaRajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"3408_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3408_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01612908","volume":"116","author":"B Vandewalle","year":"1990","unstructured":"Vandewalle B, Revillion F, Lefebvre J. Functional beta-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol. 1990;116:303\u20136.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3408_CR3","first-page":"677","volume":"11","author":"A Draoui","year":"1991","unstructured":"Draoui A, Vandewalle B, Hornez L, Revillion F, Lefebvre J. Beta-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors. Anticancer Res. 1991;11:677\u201380.","journal-title":"Anticancer Res"},{"key":"3408_CR4","doi-asserted-by":"crossref","unstructured":"Priyanka HP, Nair RS, Vasantharekha R. Role of neural-immune dysregulation in the periphery in the development of age-associated immune dysfunctions. In: Rezaei N, Yazdanpanah N, editors. Translational Neuroimmunology. Volume 7. Academic; 2023. pp. 75\u201395.","DOI":"10.1016\/B978-0-323-85841-0.00020-1"},{"key":"3408_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2014.08.001","volume":"292","author":"HP Priyanka","year":"2014","unstructured":"Priyanka HP, Singh RV, Pratap UP, ThyagaRajan S. Estrogen modulates \u03b22-adrenoceptor-induced cell-mediated and inflammatory immune responses through ER-\u03b1 involving distinct intracellular signaling pathways, antioxidant enzymes, and nitric oxide. Cell Immunol. 2014;292:1\u20138.","journal-title":"Cell Immunol"},{"key":"3408_CR6","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70:7042\u201352.","journal-title":"Cancer Res"},{"key":"3408_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.18632\/oncotarget.197","volume":"1","author":"DG Powe","year":"2010","unstructured":"Powe DG, Voss MJ, Z\u00e4nker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1:628\u201338.","journal-title":"Oncotarget"},{"key":"3408_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.18632\/oncotarget.343","volume":"2","author":"E Pasquier","year":"2011","unstructured":"Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2011;2:797\u2013809.","journal-title":"Oncotarget"},{"key":"3408_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","volume":"18","author":"SW Cole","year":"2012","unstructured":"Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18:1201\u20136.","journal-title":"Clin Cancer Res"},{"key":"3408_CR10","doi-asserted-by":"crossref","unstructured":"Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK. Neuroendocrine influences on cancer progression. Brain Behav Immun. 2013;30 Suppl:S19-25.","DOI":"10.1016\/j.bbi.2012.06.005"},{"key":"3408_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939\u201344.","journal-title":"Nat Med"},{"key":"3408_CR12","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.18632\/oncotarget.2460","volume":"5","author":"L Gargiulo","year":"2014","unstructured":"Gargiulo L, Copsel S, Rivero EM, Gal\u00e9s C, S\u00e9nard J-M, L\u00fcthy IA, et al. Differential \u03b22-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines. Oncotarget. 2014;5:10058\u201369.","journal-title":"Oncotarget"},{"key":"3408_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/CBM-130347","volume":"13","author":"EI Obeid","year":"2013","unstructured":"Obeid EI, Conzen SD. The role of adrenergic signaling in breast cancer biology. Cancer Biomark. 2013;13:161\u20139.","journal-title":"Cancer Biomark"},{"key":"3408_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5483\/BMBRep.2015.48.5.008","volume":"48","author":"J Qin","year":"2015","unstructured":"Qin J, Jin F, Li N, Guan H, Lan L, Ni H, et al. Adrenergic receptor \u03b22 activation by stress promotes breast cancer progression through macrophages M2 polarization in tumor microenvironment. BMB Rep. 2015;48:295\u2013300.","journal-title":"BMB Rep"},{"key":"3408_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/scbi.2001.0389","volume":"11","author":"S Sommer","year":"2001","unstructured":"Sommer S, Fuqua SA. Estrogen receptor and breast cancer. Semin Cancer Biol. 2001;11:339\u201352.","journal-title":"Semin Cancer Biol"},{"key":"3408_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/10408360600739218","volume":"43","author":"MJ Duffy","year":"2006","unstructured":"Duffy MJ. Estrogen receptors: role in breast cancer. Crit Rev Clin Lab Sci. 2006;43:325\u201347.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3408_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/09727531211070541","volume":"29","author":"HP Priyanka","year":"2022","unstructured":"Priyanka HP, Thiyagaraj A, Krithika G, Nair RS, Hopper W, ThyagaRajan S. 17\u03b2-Estradiol Concentration and Direct \u03b22-Adrenoceptor Inhibition Determine Estrogen-Mediated Reversal of Adrenergic Immunosuppression. Ann Neurosci. 2022;29:32\u201352.","journal-title":"Ann Neurosci"},{"key":"3408_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3934\/Neuroscience.2020025","volume":"7","author":"HP Priyanka","year":"2020","unstructured":"Priyanka HP, Nair RS. Neuroimmunomodulation by estrogen in health and disease. AIMS Neurosci. 2020;7:401\u201317.","journal-title":"AIMS Neurosci"},{"key":"3408_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","volume":"116","author":"N Fuentes","year":"2019","unstructured":"Fuentes N, Silveyra P. Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019;116:135\u201370.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"3408_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.tem.2009.06.009","volume":"20","author":"ER Levin","year":"2009","unstructured":"Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab. 2009;20:477\u201382.","journal-title":"Trends Endocrinol Metab"},{"key":"3408_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","volume":"62","author":"CK Osborne","year":"2011","unstructured":"Osborne CK, Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu Rev Med. 2011;62:233\u201347.","journal-title":"Annu Rev Med"},{"issue":"5","key":"3408_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12032-024-02322-8","volume":"41","author":"HP Priyanka","year":"2024","unstructured":"Priyanka HP, Pratap UP, Nair RS, Vasantharekha R, ThyagaRajan S. Estrogen-Receptor Status Determines Differential Regulation of \u03b11- and \u03b12-Adrenoceptor-Mediated Cell Survival, Angiogenesis, and Intracellular Signaling Responses in Breast Cancer Cell Lines. Med Onco. 2024;41(5):92.","journal-title":"Med Onco"},{"key":"3408_CR23","doi-asserted-by":"publisher","first-page":"654698","DOI":"10.1155\/2012\/654698","volume":"2012","author":"S Saha Roy","year":"2012","unstructured":"Saha Roy S, Vadlamudi RK. Role of estrogen receptor signaling in breast cancer metastasis. Int J Breast Cancer. 2012;2012:654698.","journal-title":"Int J Breast Cancer"},{"key":"3408_CR24","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.2174\/1381612822666161102100211","volume":"22","author":"NS Alamolhodaei","year":"2016","unstructured":"Alamolhodaei NS, Behravan J, Mosaffa F, Karimi G. MiR 221\/222 as New Players in Tamoxifen Resistance. Curr Pharm Des. 2016;22:6946\u201355.","journal-title":"Curr Pharm Des"},{"key":"3408_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3892\/or.2017.5360","volume":"37","author":"H Fu","year":"2017","unstructured":"Fu H, Fu L, Xie C, Zuo W-S, Liu Y-S, Zheng M-Z, et al. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer. Oncol Rep. 2017;37:1093\u20139.","journal-title":"Oncol Rep"},{"key":"3408_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00262-014-1617-9","volume":"63","author":"JW-L Eng","year":"2014","unstructured":"Eng JW-L, Kokolus KM, Reed CB, Hylander BL, Ma WW, Repasky EA. A Nervous Tumor Microenvironment: The Impact of Adrenergic Stress on Cancer Cells, Immunosuppression, and Immunotherapeutic Response. Cancer Immunol Immunother. 2014;63:1115\u201328.","journal-title":"Cancer Immunol Immunother"},{"key":"3408_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S1470-2045(04)01431-7","volume":"5","author":"F Entschladen","year":"2004","unstructured":"Entschladen F, Drell TL, Lang K, Joseph J, Zaenker KS. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol. 2004;5:254\u20138.","journal-title":"Lancet Oncol"},{"key":"3408_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-011-1348-y","volume":"130","author":"KS Madden","year":"2011","unstructured":"Madden KS, Szpunar MJ, Brown EB. \u03b2-Adrenergic receptors (\u03b2-AR) regulate VEGF and IL-6 production by divergent pathways in high \u03b2-AR-expressing breast cancer cell lines. Breast Cancer Res Treat. 2011;130:747\u201358.","journal-title":"Breast Cancer Res Treat"},{"key":"3408_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13277-012-0521-1","volume":"34","author":"BMR Vilardi","year":"2013","unstructured":"Vilardi BMR, Bravo-Calder\u00f3n DM, Bernab\u00e9 DG, Oliveira SHP, Oliveira DT. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors. Tumour Biol. 2013;34:139\u201343.","journal-title":"Tumour Biol"},{"key":"3408_CR30","doi-asserted-by":"publisher","first-page":"44732","DOI":"10.18632\/oncotarget.17267","volume":"8","author":"J Garg","year":"2017","unstructured":"Garg J, Feng Y-X, Jansen SR, Friedrich J, Lezoualc\u2019h F, Schmidt M, et al. Catecholamines facilitate VEGF-dependent angiogenesis via \u03b22-adrenoceptor-induced Epac1 and PKA activation. Oncotarget. 2017;8:44732\u201348.","journal-title":"Oncotarget"},{"key":"3408_CR31","first-page":"1352","volume":"54","author":"LL Thomsen","year":"1994","unstructured":"Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994;54:1352\u20134.","journal-title":"Cancer Res"},{"key":"3408_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00595-002-2562-3","volume":"33","author":"S Taysi","year":"2003","unstructured":"Taysi S, Uslu C, Akcay F, Sutbeyaz MY. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today. 2003;33:651\u20134.","journal-title":"Surg Today"},{"key":"3408_CR33","first-page":"727","volume":"55","author":"CS Cobbs","year":"1995","unstructured":"Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995;55:727\u201330.","journal-title":"Cancer Res"},{"key":"3408_CR34","first-page":"1215","volume":"79","author":"S Reveneau","year":"1999","unstructured":"Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest. 1999;79:1215\u201325.","journal-title":"Lab Invest"},{"key":"3408_CR35","first-page":"541","volume":"113","author":"KW Rosbe","year":"1995","unstructured":"Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 1995;113:541\u20139.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3408_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1006431309841","volume":"50","author":"M Ziche","year":"2000","unstructured":"Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol. 2000;50:139\u201348.","journal-title":"J Neurooncol"},{"key":"3408_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1005960822365","volume":"17","author":"PK Lala","year":"1998","unstructured":"Lala PK, Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev. 1998;17:91\u2013106.","journal-title":"Cancer Metastasis Rev"},{"key":"3408_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1477-7819-11-118","volume":"11","author":"SK Choudhari","year":"2013","unstructured":"Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. World J Surg Oncol. 2013;11:118.","journal-title":"World J Surg Oncol"},{"key":"3408_CR39","doi-asserted-by":"publisher","first-page":"155073","DOI":"10.1016\/j.prp.2023.155073","volume":"254","author":"SH Lee","year":"2024","unstructured":"Lee SH. Brianna null. Association of microRNA-21 expression with breast cancer subtypes and its potential as an early biomarker. Pathol Res Pract. 2024;254:155073.","journal-title":"Pathol Res Pract"},{"key":"3408_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/onc.2015.58","volume":"35","author":"D Liu","year":"2016","unstructured":"Liu D, Yang Z, Wang T, Yang Z, Chen H, Hu Y, et al. \u03b22-AR signaling controls trastuzumab resistance-dependent pathway. Oncogene. 2016;35:47\u201358.","journal-title":"Oncogene"},{"key":"3408_CR41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.18632\/oncotarget.26629","volume":"10","author":"C Papadaki","year":"2019","unstructured":"Papadaki C, Stoupis G, Tsalikis L, Monastirioti A, Papadaki M, Maliotis N, et al. Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer. Oncotarget. 2019;10:966\u201381.","journal-title":"Oncotarget"},{"key":"3408_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/2211536608666190318105757","volume":"9","author":"B Savari","year":"2020","unstructured":"Savari B, Boozarpour S, Tahmasebi-Birgani M, Sabouri H, Hosseini SM. Overexpression of microRNA-21 in the Serum of Breast Cancer Patients. Microrna. 2020;9:58\u201363.","journal-title":"Microrna"},{"key":"3408_CR43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1261\/rna.060657.117","volume":"23","author":"S Sharma","year":"2017","unstructured":"Sharma S, Nagpal N, Ghosh PC, Kulshreshtha R. P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer. RNA. 2017;23:1237\u201346.","journal-title":"RNA"},{"key":"3408_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fgene.2014.00099","volume":"5","author":"N Nagpal","year":"2014","unstructured":"Nagpal N, Kulshreshtha R. miR-191: an emerging player in disease biology. Front Genet. 2014;5:99.","journal-title":"Front Genet"},{"key":"3408_CR45","doi-asserted-by":"publisher","first-page":"e1003311","DOI":"10.1371\/journal.pgen.1003311","volume":"9","author":"G Di Leva","year":"2013","unstructured":"Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, et al. Estrogen mediated-activation of miR-191\/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 2013;9:e1003311.","journal-title":"PLoS Genet"},{"key":"3408_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/iub.1705","volume":"70","author":"X Tian","year":"2018","unstructured":"Tian X, Zhang Z. miR-191\/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer. IUBMB Life. 2018;70:71\u201380.","journal-title":"IUBMB Life"},{"key":"3408_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","volume":"12","author":"AK Sood","year":"2006","unstructured":"Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006;12:369\u201375.","journal-title":"Clin Cancer Res"},{"key":"3408_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","volume":"10","author":"D Zhang","year":"2010","unstructured":"Zhang D, Ma Q-Y, Hu H-T, Zhang M. \u03b22-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF\u03baB and AP-1. Cancer Biol Ther. 2010;10:19\u201329.","journal-title":"Cancer Biol Ther"},{"key":"3408_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/CAD.0b013e32832bd1e3","volume":"20","author":"HA Al-Wadei","year":"2009","unstructured":"Al-Wadei HA, Al-Wadei MH, Schuller HM. Prevention of pancreatic cancer by the beta-blocker propranolol. Anticancer Drugs. 2009;20:477\u201382.","journal-title":"Anticancer Drugs"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03408-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:03:33Z","timestamp":1790352213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03408-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3408"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03408-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Human participants","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"296"}}